BMP2 and metabolic dysfunction-associated steatotic liver disease: Multivariate analysis, adjusted for potential confounders (age, gender and BMI) and variables clinically relevant to NAFLD (glucose and GGT) showed that serum BMP2 concentrations persisted significantly associated with NASH (OR [95% CI], 5.07 [1.55–16.6], p = 0.007; Table 2).